Ocular Therapeutix (OCUL) SEC Filings & 10K Form

$6.17
+0.30 (+5.11%)
(As of 05/3/2024 ET)

Recent Ocular Therapeutix SEC Filings

DateFilerForm TypeView
04/29/2024
3:19 PM
Ocular Therapeutix (Filer)
Form ARS
03/29/2024
4:11 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
3:23 PM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
3:43 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
7:02 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2024
7:04 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2024
7:06 PM
Nayak Sanjay (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
7:07 PM
Dugel Pravin (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:00 AM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:34 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:48 PM
Ocular Therapeutix (Subject)
Opaleye Management Inc. (Filed by)
Form SC 13G/A
02/06/2024
5:35 PM
Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:38 PM
Ocular Therapeutix (Issuer)
White Christopher G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:26 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:29 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
5:32 PM
Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:41 PM
Ocular Therapeutix (Subject)
White Christopher G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:33 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:36 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:39 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
6:00 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:01 PM
Ocular Therapeutix (Issuer)
White Christopher G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:01 PM
Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:02 PM
Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:03 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:34 PM
Ocular Therapeutix (Subject)
Ozden Rabia Gurses (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:36 PM
Ocular Therapeutix (Subject)
White Christopher G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:39 PM
Ocular Therapeutix (Subject)
Strassburger Philip C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:41 PM
Notman Donald (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:31 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G/A
01/25/2024
7:04 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:17 PM
Ocular Therapeutix (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
12/22/2023
3:04 PM
Deep Track Capital, LP (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G
12/18/2023
3:52 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:52 PM
Ocular Therapeutix (Subject)
SUMMER ROAD LLC (Filed by)
Form SC 13D/A
12/14/2023
3:09 PM
Ocular Therapeutix (Filer)
Form 424B5
12/14/2023
7:46 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
11:15 PM
Ocular Therapeutix (Filer)
Form EFFECT
11/07/2023
4:06 PM
Ocular Therapeutix (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/04/2023
8:02 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Urgent Nvidia Warning (Ad)

Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.

Click here to access…
09/13/2023
6:07 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
7:27 AM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
7:45 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
4:18 PM
Graves Adrienne L (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/12/2023
4:18 PM
Graves Adrienne L (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
7:31 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
7:00 PM
Ocular Therapeutix (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:28 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
6:02 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:03 PM
Hong Seung Suh (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:05 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:05 PM
Ocular Therapeutix (Issuer)
RAINES MERILEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:08 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
6:09 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:21 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
5:17 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:OCUL) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners